XML 140 R106.htm IDEA: XBRL DOCUMENT v3.25.0.1
Schedule II - Cash Flows Financial Statement (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:                    
Net income (loss) $ 3,621 $ 2,790 $ 3,959 $ 4,542 $ 10,741 $ 2,698 $ 6,126 $ 4,872 $ 14,912 $ 24,437
Investment related gains (losses), net                 2,626 (760)
Federal income tax receivable                 1,398 (922)
Amortization of premiums and discounts on investments                 5,116 4,940
Depreciation                 619 515
Change in accrued investment income                 (186) (229)
Stock-based compensation                 1,517 588
Other, net                 (1,414) (1,616)
Net cash provided by operating activities                 31,918 22,056
Cash flows from investing activities:                    
Purchases of fixed maturity securities, available-for-sale                 (84,412) (72,802)
Maturities and calls of fixed maturities, available-for-sale                 51,234 29,488
Sales of fixed maturity securities, available-for-sale                 15,161 29,883
Sales of equity securities                 0 6,631
Purchases of property and equipment                 (663) (442)
Maturity of short-term investments                 0 750
Sales of short-term investments                 0 499
Net cash used in investing activities                 (27,173) (14,496)
Cash flows from financing activities:                    
Acquisition of treasury stock                 0 (919)
Other share repurchases                 (393) (60)
Net cash provided by financing activities                 (2,471) (3,536)
Net increase (decrease) in cash and cash equivalents                 2,274 4,024
Cash and cash equivalents at beginning of year       26,997       22,973 26,997 22,973
Cash and cash equivalents at end of year 29,271       26,997       29,271 26,997
Parent Company [Member]                    
Cash flows from operating activities:                    
Net income (loss)                 14,912 24,437
Investment related gains (losses), net                 17 63
Equity in income of consolidated subsidiaries                 (15,996) (27,615)
Accrued expenses and other liabilities                 4,303 (1,398)
Federal income tax receivable                 828 0
Amortization of premiums and discounts on investments                 81 107
Depreciation                 243 228
Change in accrued investment income                 32 112
Stock-based compensation                 1,517 588
Decrease (increase) in receivable from subsidiaries and other assets                 39 795
Other, net                 (23) 481
Net cash provided by operating activities                 5,953 (2,202)
Cash flows from investing activities:                    
Purchases of fixed maturity securities, available-for-sale                 (5,066) (723)
Maturities and calls of fixed maturities, available-for-sale                 9,989 6,027
Sales of fixed maturity securities, available-for-sale                 0 2,580
Sales of equity securities                 0 770
Purchases of property and equipment                 (106) (130)
Maturity of short-term investments                 0 750
Sales of short-term investments                 0 499
Net cash used in investing activities                 4,817 9,773
Cash flows from financing activities:                    
Acquisition of treasury stock                 0 (919)
Capital contribution to subsidiary                 (10,010) (4,850)
Other share repurchases                 (393) (60)
Net cash provided by financing activities                 (10,403) (5,829)
Net increase (decrease) in cash and cash equivalents                 367 1,742
Cash and cash equivalents at beginning of year       $ 3,905       $ 2,163 3,905 2,163
Cash and cash equivalents at end of year $ 4,272       $ 3,905       $ 4,272 $ 3,905